<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">RSX</journal-id>
<journal-id journal-id-type="hwp">sprsx</journal-id>
<journal-id journal-id-type="nlm-ta">Reprod Sci</journal-id>
<journal-title>Reproductive Sciences</journal-title>
<issn pub-type="ppub">1933-7191</issn>
<issn pub-type="epub">1933-7205</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1933719112450341</article-id>
<article-id pub-id-type="publisher-id">10.1177_1933719112450341</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Association of <italic>miR-146aC&gt;G</italic>, <italic>miR-196a2T&gt;C</italic>, and <italic>miR-499A&gt;G</italic> Polymorphisms With Risk of Premature Ovarian Failure in Korean Women</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rah</surname>
<given-names>HyungChul</given-names>
</name>
<degrees>DVM, PhD</degrees>
<xref ref-type="aff" rid="aff1-1933719112450341">1</xref><xref ref-type="aff" rid="aff2-1933719112450341">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jeon</surname>
<given-names>Young Joo</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="aff1-1933719112450341">1</xref><xref ref-type="aff" rid="aff2-1933719112450341">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shim</surname>
<given-names>Sung Han</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-1933719112450341">1</xref><xref ref-type="aff" rid="aff3-1933719112450341">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cha</surname>
<given-names>Sun Hee</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff4-1933719112450341">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Choi</surname>
<given-names>Dong Hee</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff4-1933719112450341">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kwon</surname>
<given-names>Hwang</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff4-1933719112450341">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Ji Hyang</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff4-1933719112450341">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shin</surname>
<given-names>Ji Eun</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff4-1933719112450341">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Kim</surname>
<given-names>Nam Keun</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-1933719112450341">1</xref><xref ref-type="aff" rid="aff2-1933719112450341">2</xref>
<xref ref-type="corresp" rid="corresp1-1933719112450341"/>
</contrib>
</contrib-group>
<aff id="aff1-1933719112450341">
<label>1</label>Department of Biomedical Science, College of Life Science, CHA University, Seongnam, South Korea</aff>
<aff id="aff2-1933719112450341">
<label>2</label>Institute for Clinical Research, CHA Bundang Medical Center, CHA University, Seongnam, South Korea</aff>
<aff id="aff3-1933719112450341">
<label>3</label>Fertility Center of CHA Gangnam Medical Center, CHA University, Seoul, South Korea</aff>
<aff id="aff4-1933719112450341">
<label>4</label>Department of Obstetrics and Gynecology, CHA Bundang Medical Center, CHA University, Seongnam, South Korea</aff>
<author-notes>
<corresp id="corresp1-1933719112450341">Nam Keun Kim, Institute for Clinical Research, CHA Bundang Medical Center, CHA University, 351 Yatap-dong, Bundang-gu, Seongnam 463-712, South Korea Email: <email>nkkim@cha.ac.kr</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2013</year>
</pub-date>
<volume>20</volume>
<issue>1</issue>
<fpage>60</fpage>
<lpage>68</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Society for Gynecologic Investigation</copyright-holder>
</permissions>
<abstract>
<p>We investigated whether microRNA (miRNA) polymorphisms (<italic>miR-146a</italic>C&gt;G, <italic>miR-196a2</italic>T&gt;C, and <italic>miR-499</italic>A&gt;G) confer risk of premature ovarian failure (POF) in Korean women. DNA samples from 136 patients with POF and 234 controls were genotyped for the 3 miRNA single-nucleotide polymorphisms by polymerase chain reaction–restriction fragment length polymorphism. The <italic>miR-146a</italic>CG/<italic>miR-196a2</italic>TC combined genotype was less frequent in patients than in controls (<italic>P</italic> &lt; .05), conferring less susceptibility. Using haplotype-based multifactor dimensionality reduction analysis, the C-C-A and G-T-A inferred haplotypes (<italic>miR-146a/miR-196a2/miR-499</italic>) were less frequent in patients, suggesting protective effects (<italic>P</italic> &lt; .05 for each), whereas the C-T-A and G-C-A haplotypes were more frequent in patients (<italic>P</italic> &lt; .05 for each). The C-T and G-C haplotypes (<italic>miR-146a/miR-196a2</italic>) were more frequent in patients, whereas the C-C and G-T haplotypes were less frequent in patients (<italic>P</italic> &lt; .05 for each). However, none of the 3 miRNA polymorphisms alone was associated with POF risk. Our findings suggest that putative gene–gene interaction between <italic>miR-146</italic> and <italic>miR-196a2</italic> may be involved in POF development.</p>
</abstract>
<kwd-group>
<kwd>premature ovarian failure</kwd>
<kwd>primary ovarian insufficiency</kwd>
<kwd>microRNA</kwd>
<kwd>single nucleotide polymorphism</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1933719112450341">
<title>Introduction</title>
<p>MicroRNAs (miRNAs) are a family of short (~22 nucleotides), noncoding, endogenous RNA molecules that regulate gene expression at the posttranscriptional level by destabilizing or cleaving target messenger RNAs (mRNAs). Approximately one third of human genes have been reported to be conserved miRNA targets, indicating that miRNAs are key regulators of various biological pathways.<sup><xref ref-type="bibr" rid="bibr1-1933719112450341">1</xref></sup> Biosynthesis of miRNAs takes several steps: initially, RNA polymerase II produces a 500 to 3000 nucleotide transcript—called the primary miRNA—that is processed to form a precursor miRNA (pre-miRNA at ~60-100 nucleotides) hairpin by a multiprotein complex that includes DROSHA. After pre-miRNA is exported to the cytoplasm by RAN and XPO5, and additionally processed by DICER1, which is a polymerase II enzyme responsible for miRNA processing, a double-stranded miRNA duplex is generated that unwinds and forms a single-stranded, mature miRNA (~22 nucleotides).<sup><xref ref-type="bibr" rid="bibr2-1933719112450341">2</xref><xref ref-type="bibr" rid="bibr3-1933719112450341"/><xref ref-type="bibr" rid="bibr4-1933719112450341"/>–<xref ref-type="bibr" rid="bibr5-1933719112450341">5</xref></sup> The mature miRNAs incorporate into the RNA-induced silencing complex and through complementary binding with target gene mRNA result in sequence-specific translational repression or mRNA degradation.<sup><xref ref-type="bibr" rid="bibr6-1933719112450341">6</xref></sup> Through this mechanism, miRNAs are considered to influence the outcome of various cellular activities under normal and disease states.<sup><xref ref-type="bibr" rid="bibr7-1933719112450341">7</xref></sup> Moreover, the association between miRNA polymorphisms and recurrent spontaneous abortion (RSA) has been reported later.<sup><xref ref-type="bibr" rid="bibr8-1933719112450341">8</xref></sup></p>
<p>Timely coordinated regulation of the expression of numerous genes are critical for optimal expression of gonadotropins, intraovarian mediators, and their receptors that mediate their intracellular actions during folliculogenesis and ovulation,<sup><xref ref-type="bibr" rid="bibr9-1933719112450341">9</xref>–<xref ref-type="bibr" rid="bibr10-1933719112450341">10</xref></sup> and alteration in the expression of these genes could lead to abnormal follicle recruitment and development.<sup><xref ref-type="bibr" rid="bibr7-1933719112450341">7</xref></sup> Since the importance of miRNAs in folliculogenesis has been illustrated by unveiling that disruption of <italic>DICER1</italic> results in failed meiotic maturation by oocytes,<sup><xref ref-type="bibr" rid="bibr11-1933719112450341">11</xref>–<xref ref-type="bibr" rid="bibr12-1933719112450341">12</xref></sup> more studies have supported the regulatory function of miRNAs in the ovary, including inhibition of antral follicle development, induction of granulosa cell apoptosis, and reduced ovulatory efficiency.<sup><xref ref-type="bibr" rid="bibr13-1933719112450341">13</xref><xref ref-type="bibr" rid="bibr14-1933719112450341"/>–<xref ref-type="bibr" rid="bibr15-1933719112450341">15</xref></sup> Recent studies have indicated the involvement of miRNAs in ovarian pathophysiology such as being involved in polycystic ovarian syndrome (PCOS) and premature ovarian failure (primary ovarian failure [POF]).<sup><xref ref-type="bibr" rid="bibr7-1933719112450341">7</xref>,<xref ref-type="bibr" rid="bibr16-1933719112450341">16</xref></sup> The PCOS, the most common cause of anovulatory infertility that affects approximately 8% of reproductive-age women,<sup><xref ref-type="bibr" rid="bibr17-1933719112450341">17</xref></sup> is characterized by arrested follicle development at the antral stage; additionally, altered expression or inappropriate signaling mechanisms of various intraovarian factors accounts for pathogenesis of PCOS.<sup><xref ref-type="bibr" rid="bibr18-1933719112450341">18</xref><xref ref-type="bibr" rid="bibr19-1933719112450341"/>–<xref ref-type="bibr" rid="bibr20-1933719112450341">20</xref></sup> Aberrant expression of the <italic>miR-29</italic> family and its specific target genes involved in folliculogenesis could result in ovarian dysfunction such as PCOS.<sup><xref ref-type="bibr" rid="bibr7-1933719112450341">7</xref>,<xref ref-type="bibr" rid="bibr21-1933719112450341">21</xref></sup> The POF affects approximately 1% of women aged less than 40 years and refers to the development of amenorrhea with elevated serum follicle-stimulating hormone (FSH) levels (&gt; 40 IU/L) due to cessation of ovarian function.<sup><xref ref-type="bibr" rid="bibr22-1933719112450341">22</xref><xref ref-type="bibr" rid="bibr23-1933719112450341"/><xref ref-type="bibr" rid="bibr24-1933719112450341"/>–<xref ref-type="bibr" rid="bibr25-1933719112450341">25</xref></sup> More than 90% of POF cases have unknown causes.<sup><xref ref-type="bibr" rid="bibr25-1933719112450341">25</xref>–<xref ref-type="bibr" rid="bibr26-1933719112450341">26</xref></sup> A recent study identified that knockout mice without <italic>miR-290</italic> through <italic>miR-295</italic> are sterile due to POF.<sup><xref ref-type="bibr" rid="bibr16-1933719112450341">16</xref></sup> <italic>miR-146a</italic> is one of the miRNAs enriched in the oocyte with dramatic changes in expression levels depending on different maturation times during bovine oocyte maturation and preimplantation embryo development.<sup><xref ref-type="bibr" rid="bibr27-1933719112450341">27</xref></sup> Targets of <italic>miR-146a</italic> include the <italic>FAS</italic> gene,<sup><xref ref-type="bibr" rid="bibr28-1933719112450341">28</xref>,<xref ref-type="bibr" rid="bibr29-1933719112450341">29</xref></sup> and FAS induces oocyte apoptosis during folliculogenesis.<sup><xref ref-type="bibr" rid="bibr30-1933719112450341">30</xref></sup> <italic>miR-196a</italic> is expressed during oocyte maturation and bovine early embryonic development and regulates the expression of the <italic>newborn ovary homeobox</italic> (<italic>NOBOX</italic>) gene during bovine early embryogenesis.<sup><xref ref-type="bibr" rid="bibr31-1933719112450341">31</xref></sup> Mutations in the <italic>NOBOX</italic> gene have been reported to cause POF.<sup><xref ref-type="bibr" rid="bibr32-1933719112450341">32</xref></sup> Very recently, we reported an interesting finding of the association between RSA risk and polymorphisms of <italic>miR-196a2</italic> and <italic>miR-499</italic>.<sup><xref ref-type="bibr" rid="bibr8-1933719112450341">8</xref></sup> <italic>miR-499</italic>, abundantly and specifically expressed only in the heart, could not be detected in other tissues in a swine model.<sup><xref ref-type="bibr" rid="bibr33-1933719112450341">33</xref></sup> However, <italic>miR-499</italic> expression was detected in an invasive breast cancer cell line,<sup><xref ref-type="bibr" rid="bibr34-1933719112450341">34</xref></sup> and a <italic>miR-499</italic> single nucleotide polymorphism (SNP) was associated with increased risk of breast cancer in Chinese women.<sup><xref ref-type="bibr" rid="bibr35-1933719112450341">35</xref></sup> Mutations of the <italic>BRCA1</italic> gene responsible for breast cancer have been reported to be associated with occult POF and suggested a potential link between breast cancer and female infertility.<sup><xref ref-type="bibr" rid="bibr36-1933719112450341">36</xref></sup> We hypothesized that miRNA polymorphisms may be associated with infertility by conferring POF risk. The purpose of the present study was to investigate the association of <italic>miR-146a</italic>C&gt;G (rs2910164), <italic>miR-196a</italic>2T&gt;C (rs11614913), and <italic>miR-49</italic>9A&gt;G (rs3746444) with POF risk.</p>
</sec>
<sec id="section2-1933719112450341" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="section3-1933719112450341">
<title>Study Participants</title>
<p>The study group consisted of 136 women (age range, 21-43 years; mean age ± standard deviation [SD], 31.34 ± 4.97 years) who were diagnosed with POF (cessation of menstruation before 40 years of age and 2 serum FSH concentration measurements &gt;40 IU/L) at the Department of Obstetrics and Gynecology of CHA Bundang Medical Center from March 1999 to February 2008. Patients with a history of pelvic surgery, cancer, radiation exposure, autoimmune disorder, or genetic syndromes were excluded from the present study. The control group consisted of 234 women (age range, 23-43 years; mean age ± SD, 32.54 ± 3.88 years) who had regular menstrual cycles and at least 1 live birth. The control group was recruited from CHA Bundang Medical Center. All patients and controls were Korean. The institutional review board of CHA Bundang Medical Center approved the study in 2006, and informed consent was obtained from all participants.</p>
</sec>
<sec id="section4-1933719112450341">
<title>Hormone Assays</title>
<p>For measurement of FSH, luteinizing hormone (LH), and estradiol (E<sub>2</sub>) levels, blood samples were collected by venipuncture on the second or third menstrual cycle day. These hormones were measured by either radioimmunoassay (E<sub>2</sub>; Beckman Coulter, Inc, Fullerton, CA) or enzyme immunoassay (FSH and LH; Siemens, Los Angeles, CA) following the manufacturer’s instructions after the serum was separated as described previously.<sup><xref ref-type="bibr" rid="bibr37-1933719112450341">37</xref></sup></p>
</sec>
<sec id="section5-1933719112450341">
<title>Genetic Analysis of miRNA Sequence Polymorphisms</title>
<p>Genomic DNA was extracted from anticoagulated peripheral blood using a G-DEX blood extraction kit (iNtRON Biotechnology, Seongnam, South Korea). The nucleotide changes were determined by polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) analysis as previously described.<sup><xref ref-type="bibr" rid="bibr38-1933719112450341">38</xref></sup> Primer sequences for PCR amplification of each polymorphism were as follows: <italic>miR-146a</italic>C&gt;G: forward 5′-CAT GGG TTG TGT CAG TGT CAG A<underline>G</underline>C T-3′ and reverse 5′-TGC CTT CTG TCT CCA GTC TTC CAA-3′ (mismatch sequence is underlined); <italic>miR-196a2</italic>T&gt;C: forward 5′-CCC CTT CCC TTC TCC TCC AGA TA-3′ and reverse 5′-CGA AAA CCG ACT GAT GTA ACT C<underline>C</underline>G-3′; and <italic>miR-499</italic>A&gt;G: forward 5′-CAA AGT CTT CAC TTC CCT GCC A-3′ and reverse 5′-GAT GTT TAA CTC CTC TCC ACG TGA <underline>T</underline>C-3′. We performed restriction enzyme digestion with <italic>Sac</italic>I and <italic>Msp</italic>I (New England BioLabs, Ipswich, Massachusetts) for the<italic> miR-146a</italic>C&gt;G and <italic>196a2</italic>T&gt;C polymorphisms, respectively, at 37°C for 16 hours, and <italic>Bcl</italic> I digestion for the <italic>499</italic>A&gt;G polymorphism at 50°C for 16 hours. We confirmed the genotyping of the 3 sites by sequencing 10% of the samples.</p>
</sec>
<sec id="section6-1933719112450341">
<title>Statistical Analysis</title>
<p>We calculated the statistical power and sample size of our study using QUANTO software version 1.2 (available at http://hydra.usc.edu/gxe/).<sup><xref ref-type="bibr" rid="bibr39-1933719112450341">39</xref>,<xref ref-type="bibr" rid="bibr40-1933719112450341">40</xref></sup> The desired power of the study was set at 80%, a 2-tailed <italic>P</italic> value &lt;.05 was deemed to indicate statistical significance, and we used the parameters (eg, minor allele frequencies) our group previously found.<sup><xref ref-type="bibr" rid="bibr8-1933719112450341">8</xref></sup> We compared the differences in hormone levels between the 2 groups using <italic>t</italic> test.</p>
<p>Differences in the genotype frequencies between controls and POF patients were compared using chi-square test or Fisher exact test. Allele frequencies were calculated to investigate deviations from Hardy-Weinberg equilibrium (HWE). Odds ratios (ORs) and 95% confidence intervals (CIs) were used to measure the strength of the association between genotypes and POF. We analyzed gene–gene interaction among the 3 miRNA loci using the multifactor-dimensionality reduction (MDR) method and MDR software version 2.0 (www.epistasis.org).<sup><xref ref-type="bibr" rid="bibr41-1933719112450341">41</xref><xref ref-type="bibr" rid="bibr42-1933719112450341"/>–<xref ref-type="bibr" rid="bibr43-1933719112450341">43</xref></sup> Using MDR method, we constructed all possible combinations of the 3 polymorphisms. We estimated inferred haplotype frequencies from haplotype-based MDR analysis using SNPAlyze version 5.1 (Dynacom Co, Ltd, Yokohama, Japan) for the polymorphisms determined to have strong synergistic effects by MDR analysis. The false discovery rate (FDR) correction was used to adjust multiple comparison tests and associations with FDR &lt;.05 were deemed to indicate statistical significance.<sup><xref ref-type="bibr" rid="bibr44-1933719112450341">44</xref></sup> Statistical analyses were performed using GraphPad Prism 4.0 (GraphPad Software Inc, San Diego, California) and StatsDirect software version 2.4.4 (StatsDirect Ltd, Altrincham, UK). Significant associations between inferred haplotypes and POF were assessed by permuting case and control status and recalculating the test statistic 1000 times for each of the sample sets. Statistical significance was accepted at <italic>P</italic> &lt; .05.</p>
</sec>
</sec>
<sec id="section7-1933719112450341">
<title>Results</title>
<p>Power calculation indicated that our study was powered to detect an association between a gene and disease, assuming an OR of 2.000 to 2.500 ( Supplement <xref ref-type="table" rid="table1-1933719112450341">Table 1</xref> for a single gene), and an association between interaction of 2 genes and disease, assuming an OR of 4.000 ( Supplement <xref ref-type="table" rid="table2-1933719112450341">Table 2</xref> for gene–gene interaction) with a power &gt;80%.</p>
<table-wrap id="table1-1933719112450341" position="float">
<label>Table 1.</label>
<caption>
<p>Demographic and Clinical Characteristics of Korean POF Patients and Controls</p>
</caption>
<graphic alternate-form-of="table1-1933719112450341" xlink:href="10.1177_1933719112450341-table1.tif"/>
<table>
<thead>
<tr>
<th>Characteristics</th>
<th>Controls</th>
<th>Patients With POF</th>
<th>
<italic>P</italic> Value<sup>a</sup>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age (years; mean ± SD [range])</td>
<td>32.54 ± 3.88 (23-43)</td>
<td>31.34 ± 4.97 (21-43)</td>
<td align="center">NS</td>
</tr>
<tr>
<td>FSH (mIU/mL; mean ± SD)</td>
<td>8.12 ± 2.88</td>
<td>66.46 ± 17.73</td>
<td>&lt;.0001</td>
</tr>
<tr>
<td>LH (mIU/mL; mean ± SD)</td>
<td>3.30 ± 1.76</td>
<td>25.95 ± 11.17</td>
<td>&lt;.0001</td>
</tr>
<tr>
<td>Estradiol (pg/mL; mean ± SD)</td>
<td>25.76 ± 14.82</td>
<td>10.27 ± 8.49</td>
<td>&lt;.0001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1933719112450341">
<p>Abbreviations: SD, standard deviation; NS, not significant; FSH, follicle-stimulating hormone; LH, luteinizing hormone; POF, premature ovarian failure.</p>
</fn>
<fn id="table-fn2-1933719112450341">
<p>
<sup>a</sup>
<italic> P</italic> value by <italic>t</italic> test.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table2-1933719112450341" position="float">
<label>Table 2.</label>
<caption>
<p>Genotype Frequencies of <italic>miR-146a</italic>C&gt;G, <italic>miR-196a2</italic>T&gt;C, and <italic>miR-499</italic>A&gt;G Polymorphisms in Korean POF Patients and Controls</p>
</caption>
<graphic alternate-form-of="table2-1933719112450341" xlink:href="10.1177_1933719112450341-table2.tif"/>
<table>
<thead>
<tr>
<th>Genotype</th>
<th>Controls, n = 234 (%)</th>
<th>Patients With POF, n = 136 (%)</th>
<th>OR (95% CI)</th>
<th>
<italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>
<italic>miR-146aC</italic>&gt;G</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> CC</td>
<td>79 (33.8)</td>
<td>51 (37.5)</td>
<td>1.000 (reference)</td>
<td>
</td>
</tr>
<tr>
<td> CG</td>
<td>125 (53.4)</td>
<td>65 (47.8)</td>
<td>0.806 (0.507–1.279)</td>
<td>.359</td>
</tr>
<tr>
<td> GG</td>
<td>30 (12.8)</td>
<td>20 (14.7)</td>
<td>1.033 (0.530–2.011)</td>
<td>.925</td>
</tr>
<tr>
<td> Dominant (CC vs CG + GG)</td>
<td>155 (66.2)</td>
<td>85 (62.5)</td>
<td>0.850 (0.547–1.320)</td>
<td>.468</td>
</tr>
<tr>
<td> Recessive (CC + CG vs GG)</td>
<td>204 (87.2)</td>
<td>116 (85.3)</td>
<td>1.172 (0.637–2.158)</td>
<td>.609</td>
</tr>
<tr>
<td> G allele</td>
<td align="center">0.395</td>
<td align="center">0.386</td>
<td> </td>
<td>
</td>
</tr>
<tr>
<td> HWE <italic>p</italic>
</td>
<td align="center">0.073</td>
<td align="center">0.923</td>
<td> </td>
<td>
</td>
</tr>
<tr>
<td>
<italic>miR-196a2T</italic>&gt;C</td>
<td>
</td>
<td>
</td>
<td> </td>
<td>
</td>
</tr>
<tr>
<td> TT</td>
<td>64 (27.4)</td>
<td>42 (30.9)</td>
<td>1.000 (reference)</td>
<td>
</td>
</tr>
<tr>
<td> TC</td>
<td>129 (55.1)</td>
<td>66 (48.5)</td>
<td>0.780 (0.478-1.272)</td>
<td>.318</td>
</tr>
<tr>
<td> CC</td>
<td>41 (17.5)</td>
<td>28 (20.6)</td>
<td>1.041 (0.561-1.932)</td>
<td>.900</td>
</tr>
<tr>
<td> Dominant (TT vs TC + CC)</td>
<td>170 (72.6)</td>
<td>94 (69.1)</td>
<td>0.843 (0.530-1.340)</td>
<td>.469</td>
</tr>
<tr>
<td> Recessive (TT + TC vs CC)</td>
<td>193 (82.5)</td>
<td>108 (79.4)</td>
<td>1.220 (0.715-2.084)</td>
<td>.465</td>
</tr>
<tr>
<td> C allele</td>
<td align="center">0.451</td>
<td align="center">0.449</td>
<td> </td>
<td>
</td>
</tr>
<tr>
<td> HWE <italic>p</italic>
</td>
<td align="center">0.083</td>
<td align="center">0.824</td>
<td> </td>
<td>
</td>
</tr>
<tr>
<td>
<italic>miR-499A</italic>&gt;G</td>
<td>
</td>
<td>
</td>
<td> </td>
<td>
</td>
</tr>
<tr>
<td> AA</td>
<td>173 (73.9)</td>
<td>96 (70.6)</td>
<td>1.000 (reference)</td>
<td>
</td>
</tr>
<tr>
<td> AG</td>
<td>58 (24.8)</td>
<td>36 (26.5)</td>
<td>1.119 (0.689-1.817)</td>
<td>.651</td>
</tr>
<tr>
<td> GG</td>
<td>3 (1.3)</td>
<td>4 (2.9)</td>
<td>2.403 (0.527-10.960)</td>
<td>.259<sup>a</sup>
</td>
</tr>
<tr>
<td> Dominant (AA vs AG + GG)</td>
<td>61 (26.1)</td>
<td>40 (29.4)</td>
<td>1.182 (0.738-1.892)</td>
<td>.486</td>
</tr>
<tr>
<td> Recessive (AA + AG vs GG)</td>
<td>231 (98.7)</td>
<td>132 (97.1)</td>
<td>2.333 (0.514-10.590)</td>
<td>.267<sup>a</sup>
</td>
</tr>
<tr>
<td> G allele</td>
<td align="center">0.137</td>
<td align="center">0.162</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> HWE <italic>p</italic>
</td>
<td align="center">0.446</td>
<td align="center">0.824</td>
<td>
</td>
<td>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-1933719112450341">
<p>Abbreviations: POF, premature ovarian failure; OR, odds ratio; CI, confidence interval; HWE <italic>p</italic>, Hardy-Weinberg equilibrium <italic>P</italic> Value.</p>
</fn>
<fn id="table-fn4-1933719112450341">
<p>
<sup>a</sup> <italic>P</italic> Value by Fisher exact test; otherwise <italic>P</italic> value by chi-square test.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Demographic and clinical characteristics, including FSH, LH, and E<sub>2</sub> levels of POF patients and controls, are summarized for comparison in <xref ref-type="table" rid="table1-1933719112450341">Table 1</xref>. The 2 groups were matched in terms of age. The patients with POF showed significantly increased FSH and LH levels and decreased E<sub>2</sub> levels compared with control women. Elevation of FSH levels with a value &gt;40 mIU/mL and less marked elevation of LH levels are indicative of POF.</p>
<p>The genotype and allele frequencies of <italic>miR-146a, miR-196a2</italic>, and <italic>miR-499</italic> polymorphisms were compared between controls and patients with POF (<xref ref-type="table" rid="table2-1933719112450341">Table 2</xref>). All genotype distributions in the study patients were in HWE. However, none of the 3 miRNA polymorphisms was alone associated with POF risk.</p>
<p>In combination analysis of the genotypes of the 3 polymorphisms (<xref ref-type="table" rid="table3-1933719112450341">Table 3</xref>), the CC/CC, CG/TT, CG/TC, and GG/TT combined genotypes for the <italic>miR-146a/miR-196a2</italic> loci were significantly less frequent in patients with POF than in controls compared with the CC/TT genotype as the reference (OR = 0.304, 95% CI = 0.107-0.869; OR = 0.422, 95% CI = 0.184-0.972; OR = 0.411, 95% CI = 0.200-0.847; OR = 0.193, 95% CI = 0.037-1.002, respectively), suggesting that these genotypes are associated with protective effects on POF. Among these combined genotypes, the CG/TC genotype remained significant after multiple comparison correction using FDR (FDR = 0.045). For the <italic>miR-146a/miR-499</italic> loci, the CG/AA combined genotype was significantly less frequent in patients with POF than in controls compared with the CC/AA genotype as the reference (OR = 0.566, 95% CI = 0.326-0.981); however, the association with POF was not significant after FDR correction (FDR = 0.063). We observed no significant association between <italic>miR-196a2/miR-499</italic> and POF occurrence.</p>
<table-wrap id="table3-1933719112450341" position="float">
<label>Table 3.</label>
<caption>
<p>Combination Analysis of <italic>miR-146a</italic>C&gt;G, <italic>miR-196a2</italic>T&gt;C, and <italic>miR-499</italic>A&gt;G Polymorphisms in Korean POF Patients and Controls</p>
</caption>
<graphic alternate-form-of="table3-1933719112450341" xlink:href="10.1177_1933719112450341-table3.tif"/>
<table>
<thead>
<tr>
<th>Genotype</th>
<th>Controls, n = 234 (%)</th>
<th>Patients With POF, n = 136 (%)</th>
<th>OR (95% CI)</th>
<th>
<italic>P</italic> Value</th>
<th>FDR</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="3">
<italic>miR-146a/miR-196a2</italic>
</td>
<td/>
<td/>
<td>
</td>
</tr>
<tr>
<td> CC/TT</td>
<td>20 (8.5)</td>
<td>23 (16.9)</td>
<td>1.000 (reference)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> CC/TC</td>
<td>39 (16.7)</td>
<td>21 (15.4)</td>
<td>0.468 (0.210-1.043)</td>
<td>.061</td>
<td>0.183</td>
</tr>
<tr>
<td> CC/CC</td>
<td>20 (8.5)</td>
<td>7 (5.1)</td>
<td>0.304 (0.107-0.869)</td>
<td>.023</td>
<td>0.069</td>
</tr>
<tr>
<td> CG/TT</td>
<td>35 (15.0)</td>
<td>17 (12.5)</td>
<td>0.422 (0.184-0.972)</td>
<td>.041</td>
<td>0.063</td>
</tr>
<tr>
<td> CG/TC</td>
<td>74 (31.6)</td>
<td>35 (25.7)</td>
<td>0.411 (0.200-0.847)</td>
<td>.015</td>
<td>0.045</td>
</tr>
<tr>
<td> CG/CC</td>
<td>16 (6.8)</td>
<td>13 (9.6)</td>
<td>0.707 (0.274-1.820)</td>
<td>.471</td>
<td>1.000</td>
</tr>
<tr>
<td> GG/TT</td>
<td>9 (3.8)</td>
<td>2 (1.5)</td>
<td>0.193 (0.037-1.002)</td>
<td>.047<sup>a</sup>
</td>
<td>0.141</td>
</tr>
<tr>
<td> GG/TC</td>
<td>16 (6.8)</td>
<td>10 (7.4)</td>
<td>0.544 (0.202-1.465)</td>
<td>.226</td>
<td>0.678</td>
</tr>
<tr>
<td> GG/CC</td>
<td>5 (2.1)</td>
<td>8 (5.9)</td>
<td>1.391 (0.391-4.945)</td>
<td>.609</td>
<td align="center">N/A</td>
</tr>
<tr>
<td colspan="2">
<italic>miR-146a/miR-499</italic>
</td>
<td/>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> CC/AA</td>
<td>52 (22.2)</td>
<td>39 (28.7)</td>
<td>1.000 (reference)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> CC/AG</td>
<td>25 (10.7)</td>
<td>10 (7.4)</td>
<td>0.533 (0.230-1.239)</td>
<td>.141</td>
<td>0.212</td>
</tr>
<tr>
<td> CC/GG</td>
<td>2 (0.9)</td>
<td>2 (1.5)</td>
<td>1.333 (0.1797-9.891)</td>
<td>1.000<sup>a</sup>
</td>
<td>1.000</td>
</tr>
<tr>
<td> CG/AA</td>
<td>99 (42.3)</td>
<td>42 (30.9)</td>
<td>0.566 (0.326-0.981)</td>
<td>.042</td>
<td>0.063</td>
</tr>
<tr>
<td> CG/AG</td>
<td>25 (10.7)</td>
<td>22 (16.2)</td>
<td>1.173 (0.578-2.381)</td>
<td>.658</td>
<td>0.794</td>
</tr>
<tr>
<td> CG/GG</td>
<td>1 (0.4)</td>
<td>1 (0.7)</td>
<td>1.333 (0.081-22.000)</td>
<td>1.000<sup>a</sup>
</td>
<td>1.000</td>
</tr>
<tr>
<td> GG/AA</td>
<td>22 (9.4)</td>
<td>15 (11.0)</td>
<td>0.909 (0.418-1.977)</td>
<td>.810</td>
<td>0.810</td>
</tr>
<tr>
<td> GG/AG</td>
<td>8 (3.4)</td>
<td>4 (2.9)</td>
<td>0.667 (0.187-2.375)</td>
<td>.757</td>
<td>0.900</td>
</tr>
<tr>
<td> GG/GG</td>
<td>0</td>
<td>1 (0.7)</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
</tr>
<tr>
<td colspan="2">
<italic>miR-196a2/miR-499</italic>
</td>
<td/>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> TT/AA</td>
<td>40 (17.1)</td>
<td>29 (21.3)</td>
<td>1.000 (reference)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> TT/AG</td>
<td>23 (9.8)</td>
<td>12 (8.8)</td>
<td>0.720 (0.309-1.677)</td>
<td>.445</td>
<td>0.445</td>
</tr>
<tr>
<td> TT/GG</td>
<td>1 (0.4)</td>
<td>1 (0.7)</td>
<td>1.379 (0.083-22.990)</td>
<td>1.000<sup>a</sup>
</td>
<td>1.000</td>
</tr>
<tr>
<td> TC/AA</td>
<td>101 (43.2)</td>
<td>47 (34.6)</td>
<td>0.642 (0.356-1.158)</td>
<td>.140</td>
<td>0.140</td>
</tr>
<tr>
<td> TC/AG</td>
<td>26 (11.1)</td>
<td>17 (12.5)</td>
<td>0.902 (0.415-1.960)</td>
<td>.794</td>
<td>0.794</td>
</tr>
<tr>
<td> TC/GG</td>
<td>2 (0.9)</td>
<td>2 (1.5)</td>
<td>1.379 (0.183-10.380)</td>
<td>1.000<sup>a</sup>
</td>
<td>1.000</td>
</tr>
<tr>
<td> CC/AA</td>
<td>32 (13.7)</td>
<td>20 (14.7)</td>
<td>0.862 (0.413-1.799)</td>
<td>.692</td>
<td>0.810</td>
</tr>
<tr>
<td> CC/AG</td>
<td>9 (3.8)</td>
<td>7 (5.1)</td>
<td>1.073 (0.358-3.215)</td>
<td>.900</td>
<td>0.900</td>
</tr>
<tr>
<td> CC/GG</td>
<td>0</td>
<td>1 (0.7)</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5-1933719112450341">
<p>Abbreviations: POF, premature ovarian failure; OR, odds ratio; CI, confidence interval; FDR, false discovery rate; N/A, not available.</p>
</fn>
<fn id="table-fn6-1933719112450341">
<p>
<sup>a</sup> <italic>P</italic> Value by Fisher exact test; otherwise <italic>P</italic> value by chi-square test.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Haplotype-based analyses of the 3 miRNA polymorphisms using the MDR method are presented in <xref ref-type="table" rid="table4-1933719112450341">Table 4</xref>. Among the inferred haplotypes for the 3 miRNAs, the C-C-A and G-T-A haplotypes were less frequent in patients with POF than in controls and conferred less POF susceptibility (OR = 0.581, 95% CI = 0.397-0.852; OR = 0.433, 95% CI = 0.274-0.683, respectively), whereas the C-T-A and G-C-A haplotypes were more frequent in patients with POF than in controls suggesting more POF susceptibility (OR = 1.717, 95% CI = 1.242-2.373; OR = 1.491, 95% CI = 1.016-2.188, respectively). In analyses of <italic>miR-146a/miR-196a2</italic>, the C-T and G-C haplotypes were more frequent in patients with POF (OR = 1.583, 95% CI = 1.159-2.162; OR = 1.822, 95% CI = 1.251-2.653, respectively), suggesting association with an increased risk of POF, whereas the C-C and G-T haplotypes were less frequent in patients with POF (OR = 0.601, 95% CI = 0.422-0.857; OR = 0.514, 95% CI = 0.345-0.766, respectively), suggesting a protective nature. Permutation tests confirmed the significance of the associations (<italic>P</italic> &lt; .05). For the <italic>miR-146a/miR-499</italic>, the G-G haplotype frequency was higher in patients with POF (OR = 1.984, 95% CI = 1.030-3.821); however, its significance was not continued after the permutation test (<italic>P</italic> = .062).</p>
<table-wrap id="table4-1933719112450341" position="float">
<label>Table 4.</label>
<caption>
<p>Haplotype-based Analysis of <italic>miR-146a</italic>C&gt;G, <italic>miR-196a2</italic>T&gt;C, and <italic>miR-499</italic>A&gt;G Polymorphisms in Korean POF Patients and Controls Using the MDR Method</p>
</caption>
<graphic alternate-form-of="table4-1933719112450341" xlink:href="10.1177_1933719112450341-table4.tif"/>
<table>
<thead>
<tr>
<th>Haplotype</th>
<th>Overall (n = 370)</th>
<th>Controls (n = 234)</th>
<th>Cases (n = 136)</th>
<th>OR (95% CI)</th>
<th>
<italic>P</italic> Value<sup>a</sup>
</th>
<th>Permutation <italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="7">
<italic>miR-146a/miR-196a2/miR-499</italic>
</td>
</tr>
<tr>
<td> C-C-A</td>
<td>0.212</td>
<td>0.258</td>
<td>0.167</td>
<td>0.581 (0.397-0.852)</td>
<td>.005</td>
<td>.007</td>
</tr>
<tr>
<td> C-T-A</td>
<td>0.301</td>
<td>0.250</td>
<td>0.358</td>
<td>1.717 (1.242-2.373)</td>
<td>.001</td>
<td>.000</td>
</tr>
<tr>
<td> G-T-A</td>
<td>0.153</td>
<td>0.202</td>
<td>0.099</td>
<td>0.433 (0.274-0.683)</td>
<td>&lt;.001</td>
<td>.001</td>
</tr>
<tr>
<td> G-C-A</td>
<td>0.188</td>
<td>0.153</td>
<td>0.215</td>
<td>1.491 (1.016-2.188)</td>
<td>.041</td>
<td>.047</td>
</tr>
<tr>
<td> C-T-G</td>
<td>0.054</td>
<td>0.057</td>
<td>0.049</td>
<td>0.820 (0.416-1.617)</td>
<td>.566</td>
<td>.607</td>
</tr>
<tr>
<td> G-T-G</td>
<td>0.042</td>
<td>0.040</td>
<td>0.046</td>
<td>1.091 (0.521-2.283)</td>
<td>.818</td>
<td>.871</td>
</tr>
<tr>
<td> C-C-G</td>
<td>0.041</td>
<td>0.040</td>
<td>0.040</td>
<td>0.996 (0.467-2.126)</td>
<td>.992</td>
<td>1.000</td>
</tr>
<tr>
<td> G-C-G</td>
<td>0.009</td>
<td>0.000</td>
<td>0.027</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
</tr>
<tr>
<td colspan="7">
<italic>miR-146a/miR-196a2</italic>
</td>
</tr>
<tr>
<td> C-T</td>
<td>0.352</td>
<td>0.304</td>
<td>0.408</td>
<td>1.583 (1.159-2.162)</td>
<td>.004</td>
<td>.004</td>
</tr>
<tr>
<td> C-C</td>
<td>0.256</td>
<td>0.301</td>
<td>0.206</td>
<td>0.601 (0.422-0.857)</td>
<td>.005</td>
<td>.002</td>
</tr>
<tr>
<td> G-T</td>
<td>0.198</td>
<td>0.245</td>
<td>0.144</td>
<td>0.514 (0.345-0.766)</td>
<td>.001</td>
<td>.001</td>
</tr>
<tr>
<td> G-C</td>
<td>0.194</td>
<td>0.150</td>
<td>0.242</td>
<td>1.822 (1.251-2.653)</td>
<td>.002</td>
<td>.006</td>
</tr>
<tr>
<td colspan="7">
<italic>miR-146a/miR-499</italic>
</td>
</tr>
<tr>
<td> C-A</td>
<td>0.511</td>
<td>0.506</td>
<td>0.524</td>
<td>1.080 (0.801-1.457)</td>
<td>.612</td>
<td>.632</td>
</tr>
<tr>
<td> G-A</td>
<td>0.343</td>
<td>0.357</td>
<td>0.314</td>
<td>0.819 (0.596-1.127)</td>
<td>.220</td>
<td>.217</td>
</tr>
<tr>
<td> C-G</td>
<td>0.097</td>
<td>0.099</td>
<td>0.090</td>
<td>0.888 (0.529-1.490)</td>
<td>.652</td>
<td>.713</td>
</tr>
<tr>
<td> G-G</td>
<td>0.049</td>
<td>0.038</td>
<td>0.072</td>
<td>1.984 (1.030-3.821)</td>
<td>.037</td>
<td>.062</td>
</tr>
<tr>
<td colspan="7">
<italic>miR-196a2/miR-499</italic>
</td>
</tr>
<tr>
<td> T-A</td>
<td>0.457</td>
<td>0.454</td>
<td>0.461</td>
<td>1.036 (0.767-1.398)</td>
<td>.819</td>
<td>.791</td>
</tr>
<tr>
<td> C-A</td>
<td>0.398</td>
<td>0.409</td>
<td>0.378</td>
<td>0.876 (0.645-1.190)</td>
<td>.398</td>
<td>.451</td>
</tr>
<tr>
<td> T-G</td>
<td>0.093</td>
<td>0.095</td>
<td>0.091</td>
<td>0.951 (0.569-1.590)</td>
<td>.849</td>
<td>.902</td>
</tr>
<tr>
<td> C-G</td>
<td>0.053</td>
<td>0.042</td>
<td>0.071</td>
<td>1.682 (0.881-3.212)</td>
<td>.111</td>
<td>.106</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn7-1933719112450341">
<p>Abbreviations: POF, premature ovarian failure; OR, odds ratio; CI, confidence interval; N/A, not available; MDR, multifactor-dimensionality reduction.</p>
</fn>
<fn id="table-fn8-1933719112450341">
<p>
<sup>a</sup>
<italic> P</italic> value by chi-square test.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section8-1933719112450341">
<title>Discussion</title>
<p>Increasing evidence has supported the roles of miRNAs in spermatogenesis and male infertility.<sup><xref ref-type="bibr" rid="bibr45-1933719112450341">45</xref><xref ref-type="bibr" rid="bibr46-1933719112450341"/><xref ref-type="bibr" rid="bibr47-1933719112450341"/><xref ref-type="bibr" rid="bibr48-1933719112450341"/>–<xref ref-type="bibr" rid="bibr49-1933719112450341">49</xref></sup> Simultaneously, evidence supporting the role of miRNAs in oocyte maturation and ovarian function has also been accumulating,<sup><xref ref-type="bibr" rid="bibr7-1933719112450341">7</xref>,<xref ref-type="bibr" rid="bibr11-1933719112450341">11</xref><xref ref-type="bibr" rid="bibr12-1933719112450341"/><xref ref-type="bibr" rid="bibr13-1933719112450341"/><xref ref-type="bibr" rid="bibr14-1933719112450341"/><xref ref-type="bibr" rid="bibr15-1933719112450341"/>–<xref ref-type="bibr" rid="bibr16-1933719112450341">16</xref>,<xref ref-type="bibr" rid="bibr27-1933719112450341">27</xref></sup> leading us to investigate whether 3 pre-miRNA SNPs (<italic>miR-146a</italic>C&gt;G<italic>, miR-196a2</italic>T&gt;C, and <italic>miR-499</italic>A&gt;G), which have been shown to associate with various types of cancer and RSA, confer risk of POF in Korean women.<sup><xref ref-type="bibr" rid="bibr8-1933719112450341">8</xref>,<xref ref-type="bibr" rid="bibr35-1933719112450341">35</xref>,<xref ref-type="bibr" rid="bibr50-1933719112450341">50</xref><xref ref-type="bibr" rid="bibr51-1933719112450341"/><xref ref-type="bibr" rid="bibr52-1933719112450341"/><xref ref-type="bibr" rid="bibr53-1933719112450341"/>–<xref ref-type="bibr" rid="bibr54-1933719112450341">54</xref></sup> To the best of our knowledge, this is the first report to evaluate the association between miRNA polymorphisms and POF risk. Our findings suggest that the <italic>miR-146a</italic> CG/<italic>miR-196a2</italic> TC combined genotype is associated with POF risk (a protective nature) relative to the CC/TT combined genotype, and its significant association was upheld after multiple comparison correction using FDR. Although none of the 3 miRNA polymorphism alone was associated with POF risk, the combined genotype of <italic>miR-146a</italic>C&gt;T and <italic>miR-196a2</italic>T&gt;C polymorphisms was associated with POF risk, suggesting potential gene–gene interaction between the 2 miRNA polymorphisms. Because gene–gene interaction may affect gene–disease association<sup><xref ref-type="bibr" rid="bibr55-1933719112450341">55</xref></sup>–<sup><xref ref-type="bibr" rid="bibr56-1933719112450341">56</xref></sup> and the MDR method is known to detect gene–gene interaction regardless of their chromosomal locations,<sup><xref ref-type="bibr" rid="bibr41-1933719112450341">41</xref><xref ref-type="bibr" rid="bibr42-1933719112450341"/>–<xref ref-type="bibr" rid="bibr43-1933719112450341">43</xref></sup> we took a novel approach to examine potential interactive effects of different miRNAs on POF risk using haplotype-based MDR analysis, although linkage disequilibrium was not found among the miRNAs. Previously, we took this approach to evaluate synergistic effects of the pre-miRNA polymorphisms on idiopathic RSA risk.<sup><xref ref-type="bibr" rid="bibr8-1933719112450341">8</xref></sup> The haplotype-based MDR analysis of the 3 miRNA polymorphisms also suggested gene–gene interaction between <italic>miR-146a</italic>C&gt;G and <italic>miR-196a2</italic>T&gt;C polymorphisms (<italic>miR-146a</italic>C/<italic>miR-19a2</italic>C and <italic>miR-146a</italic>G/<italic>miR-196a2</italic>T inferred haplotypes as a protective factor; <italic>miR-146a</italic>C/<italic>miR-196a2</italic>T and <italic>miR-146a</italic>G/<italic>miR-196a2</italic>C inferred haplotypes as a risk factor). More combined genotypes (CC/CC, CG/TT, and GG/TT combined genotypes of <italic>miR-146a</italic> C&gt;G/<italic>miR-196a2</italic> T&gt;C loci; the CG/AA combined genotype of <italic>miR-146a</italic> C&gt;G/<italic>miR-499</italic> A&gt;G loci) also have protective effects against POF occurrence; however, its significance did not last after FDR correction.</p>
<p>Among the 3 miRNAs investigated in our study, <italic>miR-146a</italic> is expressed in the oocyte during bovine oocyte maturation and preimplantation embryo development and has a putative target site in the 3′-untranslated region (UTR) of <italic>FAS</italic> mRNA to regulate <italic>FAS</italic> expression.<sup><xref ref-type="bibr" rid="bibr27-1933719112450341">27</xref>–<xref ref-type="bibr" rid="bibr28-1933719112450341">28</xref></sup> The <italic>FAS</italic> gene is expressed in both unfertilized oocytes and cumulus cells and coordinate oocyte apoptosis during folliculogenesis by binding with FAS ligand on oocytes, which may result in caspase 8 activation.<sup><xref ref-type="bibr" rid="bibr29-1933719112450341">29</xref>,<xref ref-type="bibr" rid="bibr30-1933719112450341">30</xref></sup> <italic>miR-146a</italic>, which is NF-κB dependent for its induction, is also involved in regulation of the tumor necrosis factor (TNF)-α pathway by targeting TNF receptor-associated factor 6.<sup><xref ref-type="bibr" rid="bibr57-1933719112450341">57</xref>,<xref ref-type="bibr" rid="bibr58-1933719112450341">58</xref></sup> The TNF-α, expressed in granulosa cells, is involved in follicular development and atresia by activating a cascade of caspases like FAS-FAS ligand.<sup><xref ref-type="bibr" rid="bibr59-1933719112450341">59</xref><xref ref-type="bibr" rid="bibr60-1933719112450341"/>–<xref ref-type="bibr" rid="bibr61-1933719112450341">61</xref></sup> <italic>miR-196a</italic>, detected significantly in fetal and adult ovary, binds to the 3′-UTR of bovine <italic>NOBOX</italic> mRNA and significantly inhibits <italic>NOBOX</italic> expression in vitro.<sup><xref ref-type="bibr" rid="bibr31-1933719112450341">31</xref></sup> The <italic>NOBOX</italic> gene, preferentially expressed in primordial and growing oocytes, is a regulator of the development of primordial to primary follicles and is associated with POF.<sup><xref ref-type="bibr" rid="bibr32-1933719112450341">32</xref>,<xref ref-type="bibr" rid="bibr62-1933719112450341">62</xref>,<xref ref-type="bibr" rid="bibr63-1933719112450341">63</xref></sup> <italic>miR-499</italic> is expressed specifically in the heart, and direct evidence for involvement of <italic>miR-499</italic> in ovarian function has yet to be reported. However, targets of <italic>miR-499</italic> include the transcriptional repressor <italic>SOX6</italic> gene that represses transcription from the fibroblast growth factor (FGF)-3 promoter.<sup><xref ref-type="bibr" rid="bibr33-1933719112450341">33</xref>,<xref ref-type="bibr" rid="bibr64-1933719112450341">64</xref>,<xref ref-type="bibr" rid="bibr65-1933719112450341">65</xref></sup> The FGF-3 is known to play a role in cell proliferation and differentiation in embryonic tissues<sup><xref ref-type="bibr" rid="bibr66-1933719112450341">66</xref></sup> and is associated with the risk of breast and ovarian cancers.<sup><xref ref-type="bibr" rid="bibr67-1933719112450341">67</xref>,<xref ref-type="bibr" rid="bibr68-1933719112450341">68</xref></sup> Interestingly, <italic>miR-499</italic> expression was detected in an invasive breast cancer cell line,<sup><xref ref-type="bibr" rid="bibr33-1933719112450341">33</xref>,<xref ref-type="bibr" rid="bibr34-1933719112450341">34</xref></sup> and the <italic>miR-499</italic>A&gt;G polymorphism was associated with an increased risk of breast cancer in Chinese women.<sup><xref ref-type="bibr" rid="bibr35-1933719112450341">35</xref></sup> <italic>BRCA1</italic> mutation-positive breast patients have been reported to demonstrate a significantly higher risk of low response to ovarian stimulation (lower numbers of eggs), suggesting a potential link between breast cancer and female infertility.<sup><xref ref-type="bibr" rid="bibr36-1933719112450341">36</xref></sup> We also found that <italic>miR-499</italic>A&gt;G polymorphism as well as <italic>miR-196a2</italic>T&gt;C polymorphism is associated with idiopathic RSA in Korean women.<sup><xref ref-type="bibr" rid="bibr8-1933719112450341">8</xref></sup> However, we found no significant association between the <italic>miR-499</italic>A&gt;G polymorphism and POF risk in our study.</p>
<p>It is anticipated that miRNAs may work in combination because the interactions among the miRNAs have been suggested as necessary for more precise specification of the set of affected targets of each miRNA.<sup><xref ref-type="bibr" rid="bibr69-1933719112450341">69</xref></sup> One way to estimate the interactions of miRNAs is to identify pairs of miRNAs that show a high rate of co-occurrence in the same target mRNAs, such as predicted pairs of co-regulating miRNAs.<sup><xref ref-type="bibr" rid="bibr69-1933719112450341">69</xref></sup> Our findings showed that the <italic>miR-146a</italic>C allele in relation to the <italic>miR-196a2</italic>T allele increased POF risk, whereas <italic>miR-146a</italic>C in relation to <italic>miR-196a2</italic>C decreased POF risk, suggesting the interaction between <italic>miR-146a</italic> and<italic> miR-196a2</italic> polymorphisms is associated with the risk of POF. Our speculation for the interactive effects of polymorphisms of the 2 miRNAs on POF risk, however, requires evidence from in vitro functional data in further studies to provide a similar proof of principle to evaluate synergistic effects among the miRNAs tested.<sup><xref ref-type="bibr" rid="bibr70-1933719112450341">70</xref></sup></p>
<p>Polymorphisms in pre-miRNAs can affect the levels of mature miRNAs as <italic>miR-146a</italic>G and <italic>miR-196a2</italic>T alleles decrease corresponding mature miRNA levels.<sup><xref ref-type="bibr" rid="bibr50-1933719112450341">50</xref>,<xref ref-type="bibr" rid="bibr53-1933719112450341">53</xref>,<xref ref-type="bibr" rid="bibr71-1933719112450341">71</xref>,<xref ref-type="bibr" rid="bibr72-1933719112450341">72</xref></sup> Upregulated <italic>miR-196a2</italic> has been reported to affect mRNA expression of the <italic>HOX</italic> family and AKT signaling, which is linked to endometriosis.<sup><xref ref-type="bibr" rid="bibr73-1933719112450341">73</xref><xref ref-type="bibr" rid="bibr74-1933719112450341"/>–<xref ref-type="bibr" rid="bibr75-1933719112450341">75</xref></sup> Spatiotemporal aberrations in <italic>HOX</italic> gene expression are implicated in endometriosis as well as PCOS.<sup><xref ref-type="bibr" rid="bibr73-1933719112450341">73</xref></sup> We conjectured that sequence polymorphisms of <italic>miR-146a</italic> and <italic>miR-196a2</italic> may affect folliculogenesis by altering miRNA biogenesis and subsequently target genes of the miRNAs. Due to limited access to ovary samples from patients with POF, however, we could not compare expression levels of miRNAs and target genes according to the miRNA genotypes, which may be a major challenge for our study. Although underlying mechanisms of the <italic>miR-146a</italic> and <italic>miR-196a2</italic> polymorphisms in the development of POF have not been demonstrated in our study, previous studies on the miRNAs and their target genes led us to postulate their potential role in oocyte apoptosis during folliculogenesis. Another weakness of our study is that a replication study to verify our findings is warranted. Our study is also limited by the number of cases and controls. As the power calculation indicated, our sample size was large enough to detect an association between POF and <italic>miR-499</italic> polymorphisms, although the association was not significant. However, our study did not have sufficient power to detect the association between POF and individual <italic>miR-146a</italic> or <italic>miR-196a2</italic> polymorphisms. For the gene–gene interaction model, our study with samples was sufficient to detect the association between POF, and the interaction of <italic>miR-196a2</italic> and <italic>miR-499</italic> failed to detect a significant association. However, the present study detected an association between POF and interaction of <italic>miR-146a</italic> and <italic>miR-196a2</italic> when the estimated power was &lt;80%. A lack of association between POF and individual <italic>miR-146a</italic> or <italic>miR-196a2</italic> polymorphisms, but significant association between POF and the interaction of <italic>miR-146a</italic> and <italic>miR-196a2</italic>, may indicate that a larger number of samples is needed to present a single gene effect on POF risk.</p>
<p>In conclusion, we have identified that combined polymorphisms and inferred haplotypes of <italic>miR-146a</italic>C&gt;G, <italic>miR-196a2T</italic>&gt;C, and <italic>miR-499</italic>A&gt;G are associated with the occurrence of POF in Korean women. Our data demonstrated that the <italic>miR-146a</italic>C allele in combination with the <italic>miR-196a2</italic>C allele as well as the <italic>miR-146a</italic>G allele in combination with the <italic>miR-196a2</italic>T allele reduced POF risk. However, the <italic>miR-146a</italic>C allele in combination with the <italic>miR-196a2</italic>T allele as well as the <italic>miR-146a</italic>G allele in combination with the <italic>miR-196a2</italic>C allele increased POF risk. Considering that none of the 3 miRNAs alone is associated with POF risk, our findings suggest that the gene–gene interaction between <italic>miR-146</italic> and <italic>miR-196a2</italic> may be involved in POF development. We postulated that transcriptional aberration of <italic>miR-146a</italic> and <italic>miR-196a2</italic> induced by miRNA SNPs might influence target gene expression and subsequently, oocyte apoptosis during folliculogenesis, although the underlying mechanism remains to be elucidated in further studies.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict" id="fn1-1933719112450341"><label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-1933719112450341"><label>Funding</label>
<p>The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: partly supported by Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology Republic of Korea (2009-0093821), and by grant of the Korea Healthcare technology R&amp;D Project, Ministry for Health, Welfare &amp; Family Affairs, Republic of Korea (A084923).</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1933719112450341">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewis</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Burge</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Bartel</surname>
<given-names>DP</given-names>
</name>
</person-group>. <article-title>Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets</article-title>. <source>Cell</source>. <year>2005</year>;<volume>120</volume>(<issue>1</issue>):<fpage>15</fpage>–<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr2-1933719112450341">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ambros</surname>
<given-names>V</given-names>
</name>
</person-group>. <article-title>The functions of animal microRNAs</article-title>. <source>Nature</source>. <year>2004</year>;<volume>431</volume>(<issue>7006</issue>):<fpage>350</fpage>–<lpage>355</lpage>.</citation>
</ref>
<ref id="bibr3-1933719112450341">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartel</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>CZ</given-names>
</name>
</person-group>. <article-title>Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs</article-title>. <source>Nat Rev Genet</source>. <year>2004</year>;<volume>5</volume>(<issue>5</issue>):<fpage>396</fpage>–<lpage>400</lpage>.</citation>
</ref>
<ref id="bibr4-1933719112450341">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lund</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Guttinger</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Calado</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dahlberg</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Kutay</surname>
<given-names>U</given-names>
</name>
</person-group>. <article-title>Nuclear export of microRNA precursors</article-title>. <source>Science</source>. <year>2004</year>;<volume>303</volume>(<issue>5654</issue>):<fpage>95</fpage>–<lpage>98</lpage>.</citation>
</ref>
<ref id="bibr5-1933719112450341">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zamore</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Haley</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Ribo-gnome: the big world of small RNAs</article-title>. <source>Science</source>. <year>2005</year>;<volume>309</volume>(<issue>5740</issue>):<fpage>1519</fpage>–<lpage>1524</lpage>.</citation>
</ref>
<ref id="bibr6-1933719112450341">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O'Toole</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Haines</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zink</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Serra</surname>
<given-names>MJ</given-names>
</name>
</person-group>. <article-title>Comprehensive thermodynamic analysis of 3' double-nucleotide overhangs neighboring Watson-Crick terminal base pairs</article-title>. <source>Nucleic Acids Res</source>. <year>2006</year>;<volume>34</volume>(<issue>11</issue>):<fpage>3338</fpage>–<lpage>3344</lpage>.</citation>
</ref>
<ref id="bibr7-1933719112450341">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toloubeydokhti</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bukulmez</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Chegini</surname>
<given-names>N</given-names>
</name>
</person-group>. <article-title>Potential regulatory functions of microRNAs in the ovary</article-title>. <source>Semin Reprod Med</source>. <year>2008</year>;<volume>26</volume>(<issue>6</issue>):<fpage>469</fpage>–<lpage>478</lpage>.</citation>
</ref>
<ref id="bibr8-1933719112450341">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeon</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Rah</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group> <article-title>Association study of microRNA polymorphisms with risk of idiopathic recurrent spontaneous abortion in Korean women</article-title>. <source>Gene</source>. <year>2012</year>;<volume>494</volume>(<issue>2</issue>):<fpage>168</fpage>–<lpage>173</lpage>.</citation>
</ref>
<ref id="bibr9-1933719112450341">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albertini</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Barrett</surname>
<given-names>SL</given-names>
</name>
</person-group>. <article-title>Oocyte-somatic cell communication</article-title>. <source>Reprod Suppl</source>. <year>2003</year>;<volume>61</volume>:<fpage>49</fpage>–<lpage>54</lpage>.</citation>
</ref>
<ref id="bibr10-1933719112450341">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Assou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Anahory</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Pantesco</surname>
<given-names>V</given-names>
</name>
<etal/>
</person-group> <article-title>The human cumulus—oocyte complex gene-expression profile</article-title>. <source>Hum Reprod</source>. <year>2006</year>;<volume>21</volume>(<issue>7</issue>):<fpage>1705</fpage>–<lpage>1719</lpage>.</citation>
</ref>
<ref id="bibr11-1933719112450341">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murchison</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Xuan</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group> <article-title>Critical roles for Dicer in the female germline</article-title>. <source>Genes Dev</source>. <year>2007</year>;<volume>21</volume>(<issue>6</issue>):<fpage>682</fpage>–<lpage>693</lpage>.</citation>
</ref>
<ref id="bibr12-1933719112450341">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Kaneda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>O'Carroll</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group> <article-title>Maternal microRNAs are essential for mouse zygotic development</article-title>. <source>Genes Dev</source>. <year>2007</year>;<volume>21</volume>(<issue>6</issue>):<fpage>644</fpage>–<lpage>648</lpage>.</citation>
</ref>
<ref id="bibr13-1933719112450341">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Luense</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>McGinnis</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Nothnick</surname>
<given-names>WB</given-names>
</name>
<name>
<surname>Christenson</surname>
<given-names>LK</given-names>
</name>
</person-group>. <article-title>Dicer1 is essential for female fertility and normal development of the female reproductive system</article-title>. <source>Endocrinology</source>. <year>2008</year>;<volume>149</volume>(<issue>12</issue>):<fpage>6207</fpage>–<lpage>6212</lpage>.</citation>
</ref>
<ref id="bibr14-1933719112450341">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagaraja</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Andreu-Vieyra</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Franco</surname>
<given-names>HL</given-names>
</name>
<etal/>
</person-group> <article-title>Deletion of Dicer in somatic cells of the female reproductive tract causes sterility</article-title>. <source>Mol Endocrinol</source>. <year>2008</year>;<volume>22</volume>(<issue>10</issue>):<fpage>2336</fpage>–<lpage>2352</lpage>.</citation>
</ref>
<ref id="bibr15-1933719112450341">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Behringer</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Woodruff</surname>
<given-names>TK</given-names>
</name>
</person-group>. <article-title>The regulatory role of Dicer in folliculogenesis in mice</article-title>. <source>Mol Cell Endocrinol</source>. <year>2010</year>;<volume>315</volume>(<issue>1-2</issue>):<fpage>63</fpage>–<lpage>73</lpage>.</citation>
</ref>
<ref id="bibr16-1933719112450341">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Medeiros</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Dennis</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>ME</given-names>
</name>
<etal/>
</person-group> <article-title>Mir-290-295 deficiency in mice results in partially penetrant embryonic lethality and germ cell defects</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2011</year>;<volume>108</volume>(<issue>34</issue>):<fpage>14163</fpage>–<lpage>14168</lpage>.</citation>
</ref>
<ref id="bibr17-1933719112450341">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Legro</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Barnhart</surname>
<given-names>HX</given-names>
</name>
<name>
<surname>Schlaff</surname>
<given-names>WD</given-names>
</name>
<etal/>
</person-group> <article-title>Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome</article-title>. <source>N Engl J Med</source>. <year>2007</year>;<volume>356</volume>(<issue>6</issue>):<fpage>551</fpage>–<lpage>566</lpage>.</citation>
</ref>
<ref id="bibr18-1933719112450341">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dumesic</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Abbott</surname>
<given-names>DH</given-names>
</name>
</person-group>. <article-title>Implications of polycystic ovary syndrome on oocyte development</article-title>. <source>Semin Reprod Med</source>. <year>2008</year>;<volume>26</volume>(<issue>1</issue>):<fpage>53</fpage>–<lpage>61</lpage>.</citation>
</ref>
<ref id="bibr19-1933719112450341">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wood</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Dumesic</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Abbott</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Strauss</surname>
<given-names>JF</given-names>
<suffix>3rd</suffix>
</name>
</person-group>. <article-title>Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2007</year>;<volume>92</volume>(<issue>2</issue>):<fpage>705</fpage>–<lpage>713</lpage>.</citation>
</ref>
<ref id="bibr20-1933719112450341">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hughes</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Elgasim</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Layfield</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Atiomo</surname>
<given-names>W</given-names>
</name>
</person-group>. <article-title>Genomic and post-genomic approaches to polycystic ovary syndrome—progress so far: mini review</article-title>. <source>Hum Reprod</source>. <year>2006</year>;<volume>21</volume>(<issue>11</issue>):<fpage>2766</fpage>–<lpage>2775</lpage>.</citation>
</ref>
<ref id="bibr21-1933719112450341">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>F</given-names>
</name>
</person-group>. <article-title>Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes</article-title>. <source>Mol Endocrinol</source>. <year>2007</year>;<volume>21</volume>(<issue>11</issue>):<fpage>2785</fpage>–<lpage>2794</lpage>.</citation>
</ref>
<ref id="bibr22-1933719112450341">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coulam</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Adamson</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Annegers</surname>
<given-names>JF</given-names>
</name>
</person-group>. <article-title>Incidence of premature ovarian failure</article-title>. <source>Obstet Gynecol</source>. <year>1986</year>;<volume>67</volume>(<issue>4</issue>):<fpage>604</fpage>–<lpage>606</lpage>.</citation>
</ref>
<ref id="bibr23-1933719112450341">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rebar</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>Connolly</surname>
<given-names>HV</given-names>
</name>
</person-group>. <article-title>Clinical features of young women with hypergonadotropic amenorrhea</article-title>. <source>Fertil Steril</source>. <year>1990</year>;<volume>53</volume>(<issue>5</issue>):<fpage>804</fpage>–<lpage>810</lpage>.</citation>
</ref>
<ref id="bibr24-1933719112450341">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conway</surname>
<given-names>GS</given-names>
</name>
</person-group>. <article-title>Premature ovarian failure</article-title>. <source>Br Med Bull</source>. <year>2000</year>;<volume>56</volume>(<issue>3</issue>):<fpage>643</fpage>–<lpage>649</lpage>.</citation>
</ref>
<ref id="bibr25-1933719112450341">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nelson</surname>
<given-names>LM.</given-names>
</name>
</person-group> <article-title>Clinical practice. Primary ovarian insufficiency</article-title>. <source>N Engl J Med</source>. <year>2009</year>;<volume>360</volume>(<issue>6</issue>):<fpage>606</fpage>–<lpage>614</lpage>.</citation>
</ref>
<ref id="bibr26-1933719112450341">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goswami</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Conway</surname>
<given-names>GS</given-names>
</name>
</person-group>. <article-title>Premature ovarian failure</article-title>. <source>Hum Reprod Update</source>. <year>2005</year>;<volume>11</volume>(<issue>4</issue>):<fpage>391</fpage>–<lpage>410</lpage>.</citation>
</ref>
<ref id="bibr27-1933719112450341">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abd</surname>
<given-names>El Naby WS</given-names>
</name>
<name>
<surname>Hagos</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Hossain</surname>
<given-names>MM</given-names>
</name>
<etal/>
</person-group> <article-title>Expression analysis of regulatory microRNAs in bovine cumulus oocyte complex and preimplantation embryos</article-title>. <source>Zygote</source>. <year>2011</year>:<fpage>1</fpage>–<lpage>21</lpage>.</citation>
</ref>
<ref id="bibr28-1933719112450341">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Ashraf</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Haider</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>Diazoxide potentiates mesenchymal stem cell survival via NF-kappaB-dependent miR-146a expression by targeting Fas</article-title>. <source>Am J Physiol Heart Circ Physiol</source>. <year>2010</year>;<volume>299</volume>(<issue>4</issue>):<fpage>H1077</fpage>–<lpage>1082</lpage>.</citation>
</ref>
<ref id="bibr29-1933719112450341">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jose de los Santos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Racowsky</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>JA</given-names>
</name>
</person-group>. <article-title>Presence of Fas-Fas ligand system and bcl-2 gene products in cells and fluids from gonadotropin-stimulated human ovaries</article-title>. <source>Biol Reprod</source>. <year>2000</year>;<volume>63</volume>(<issue>6</issue>):<fpage>1811</fpage>–<lpage>1816</lpage>.</citation>
</ref>
<ref id="bibr30-1933719112450341">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reynaud</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Driancourt</surname>
<given-names>MA</given-names>
</name>
</person-group>. <article-title>Oocyte attrition</article-title>. <source>Mol Cell Endocrinol</source>. <year>2000</year>;<volume>163</volume>(<issue>1-2</issue>):<fpage>101</fpage>–<lpage>108</lpage>.</citation>
</ref>
<ref id="bibr31-1933719112450341">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tripurani</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>KB</given-names>
</name>
<name>
<surname>Wee</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>MicroRNA-196a regulates bovine newborn ovary homeobox gene (NOBOX) expression during early embryogenesis</article-title>. <source>BMC Dev Biol</source>. <year>2011</year>;<volume>11</volume>:<fpage>25</fpage>.</citation>
</ref>
<ref id="bibr32-1933719112450341">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>ZJ</given-names>
</name>
<name>
<surname>Rajkovic</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>NOBOX homeobox mutation causes premature ovarian failure</article-title>. <source>Am J Hum Genet</source>. <year>2007</year>;<volume>81</volume>(<issue>3</issue>):<fpage>576</fpage>–<lpage>581</lpage>.</citation>
</ref>
<ref id="bibr33-1933719112450341">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reddy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Jagadeeswaran</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group> <article-title>Cloning, characterization and expression analysis of porcine microRNAs</article-title>. <source>BMC Genomics</source>. <year>2009</year>;<volume>10</volume>:<fpage>65</fpage>.</citation>
</ref>
<ref id="bibr34-1933719112450341">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Landgraf</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rusu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sheridan</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group> <article-title>A mammalian microRNA expression atlas based on small RNA library sequencing</article-title>. <source>Cell</source>. <year>2007</year>;<volume>129</volume>(<issue>7</issue>):<fpage>1401</fpage>–<lpage>1414</lpage>.</citation>
</ref>
<ref id="bibr35-1933719112450341">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group> <article-title>Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women</article-title>. <source>Hum Mutat</source>. <year>2009</year>;<volume>30</volume>(<issue>1</issue>):<fpage>79</fpage>–<lpage>84</lpage>.</citation>
</ref>
<ref id="bibr36-1933719112450341">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oktay</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Barad</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Babayev</surname>
<given-names>SN</given-names>
</name>
</person-group>. <article-title>Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks</article-title>. <source>J Clin Oncol</source>. <year>2010</year>;<volume>28</volume>(<issue>2</issue>):<fpage>240</fpage>–<lpage>244</lpage>.</citation>
</ref>
<ref id="bibr37-1933719112450341">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>KH</given-names>
</name>
<etal/>
</person-group> <article-title>Expression pattern of endothelin system components and localization of smooth muscle cells in the human pre-ovulatory follicle</article-title>. <source>Hum Reprod</source>. <year>2011</year>;<volume>26</volume>(<issue>5</issue>):<fpage>1171</fpage>–<lpage>1180</lpage>.</citation>
</ref>
<ref id="bibr38-1933719112450341">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group> <article-title>Genetic variants of miRNA sequences and non-small cell lung cancer survival</article-title>. <source>J Clin Invest</source>. <year>2008</year>;<volume>118</volume>(<issue>7</issue>):<fpage>2600</fpage>–<lpage>2608</lpage>.</citation>
</ref>
<ref id="bibr39-1933719112450341">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gauderman</surname>
<given-names>WJ</given-names>
</name>
</person-group>. <article-title>Sample size requirements for association studies of gene-gene interaction</article-title>. <source>Am J Epidemiol</source>. <year>2002</year>;<volume>155</volume>(<issue>5</issue>):<fpage>478</fpage>–<lpage>484</lpage>.</citation>
</ref>
<ref id="bibr40-1933719112450341">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gauderman</surname>
<given-names>WJ</given-names>
</name>
</person-group>. <article-title>Sample size requirements for matched case-control studies of gene-environment interaction</article-title>. <source>Stat Med</source>. <year>2002</year>;<volume>21</volume>(<issue>1</issue>):<fpage>35</fpage>–<lpage>50</lpage>.</citation>
</ref>
<ref id="bibr41-1933719112450341">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hahn</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Ritchie</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>JH</given-names>
</name>
</person-group>. <article-title>Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions</article-title>. <source>Bioinformatics</source>. <year>2003</year>;<volume>19</volume>(<issue>3</issue>):<fpage>376</fpage>–<lpage>382</lpage>.</citation>
</ref>
<ref id="bibr42-1933719112450341">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moore</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>SM</given-names>
</name>
</person-group>. <article-title>New strategies for identifying gene-gene interactions in hypertension</article-title>. <source>Ann Med</source>. <year>2002</year>;<volume>34</volume>(<issue>2</issue>):<fpage>88</fpage>–<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr43-1933719112450341">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ritchie</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Hahn</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Roodi</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group> <article-title>Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer</article-title>. <source>Am J Hum Genet</source>. <year>2001</year>;<volume>69</volume>(<issue>1</issue>):<fpage>138</fpage>–<lpage>147</lpage>.</citation>
</ref>
<ref id="bibr44-1933719112450341">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benjamini</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hochberg</surname>
<given-names>Y</given-names>
</name>
</person-group>. <article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title>. <source>J R Stat Soc Ser B Stat Methodol</source>. <year>1995</year>;<volume>57</volume>(<issue>1</issue>):<fpage>289</fpage>–<lpage>300</lpage>.</citation>
</ref>
<ref id="bibr45-1933719112450341">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Curry</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Safranski</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Pratt</surname>
<given-names>SL</given-names>
</name>
</person-group>. <article-title>Differential expression of porcine sperm microRNAs and their association with sperm morphology and motility</article-title>. <source>Theriogenology</source>. <year>2011</year>;<volume>76</volume>(<issue>8</issue>):<fpage>1532</fpage>–<lpage>1539</lpage>.</citation>
</ref>
<ref id="bibr46-1933719112450341">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Kokkinaki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pant</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gallicano</surname>
<given-names>GI</given-names>
</name>
<name>
<surname>Dym</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Small RNA molecules in the regulation of spermatogenesis</article-title>. <source>Reproduction</source>. <year>2009</year>;<volume>137</volume>(<issue>6</issue>):<fpage>901</fpage>–<lpage>911</lpage>.</citation>
</ref>
<ref id="bibr47-1933719112450341">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papaioannou</surname>
<given-names>MD</given-names>
</name>
</person-group>, <article-title>Nef S. microRNAs in the testis: building up male fertility</article-title>. <source>J Androl</source>. <year>2010</year>;<volume>31</volume>(<issue>1</issue>):<fpage>26</fpage>–<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr48-1933719112450341">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<etal/>
</person-group> <article-title>Altered profile of seminal plasma microRNAs in the molecular diagnosis of male infertility</article-title>. <source>Clin Chem</source>. <year>2011</year>;<volume>57</volume>(<issue>12</issue>):<fpage>1722</fpage>–<lpage>1731</lpage>.</citation>
</ref>
<ref id="bibr49-1933719112450341">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group> <article-title>A single nucleotide polymorphism in a miR-1302 binding site in CGA increases the risk of idiopathic male infertility</article-title>. <source>Fertil Steril</source>. <year>2011</year>;<volume>96</volume>(<issue>1</issue>):<fpage>34</fpage>–<lpage>39</lpage> e37.</citation>
</ref>
<ref id="bibr50-1933719112450341">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffman</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>T</given-names>
</name>
</person-group>, <article-title>Yi C, et al. microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis</article-title>. <source>Cancer Res</source>. <year>2009</year>;<volume>69</volume>(<issue>14</issue>):<fpage>5970</fpage>–<lpage>5977</lpage>.</citation>
</ref>
<ref id="bibr51-1933719112450341">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Min</surname>
<given-names>KT</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>YJ</given-names>
</name>
<etal/>
</person-group> <article-title>Association of the miR-146aC&gt;G, 149C&gt;T, 196a2C&gt;T, and 499A&gt;G polymorphisms with colorectal cancer in the Korean population</article-title>. <source>Mol Carcinog</source>. <year>2011</year>;<comment>DOI: 10.1002/mc.21849</comment>.</citation>
</ref>
<ref id="bibr52-1933719112450341">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ryan</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Robles</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>CC</given-names>
</name>
</person-group>. <article-title>Genetic variation in microRNA networks: the implications for cancer research</article-title>. <source>Nat Rev Cancer</source>. <year>2010</year>;<volume>10</volume>(<issue>6</issue>):<fpage>389</fpage>–<lpage>402</lpage>.</citation>
</ref>
<ref id="bibr53-1933719112450341">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>. <year>2009</year>;<volume>18</volume>(<issue>4</issue>):<fpage>1183</fpage>–<lpage>1187</lpage>.</citation>
</ref>
<ref id="bibr54-1933719112450341">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group> <article-title>Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population</article-title>. <source>Hum Mutat</source>. <year>2009</year>;<volume>30</volume>(<issue>8</issue>):<fpage>1231</fpage>–<lpage>1236</lpage>.</citation>
</ref>
<ref id="bibr55-1933719112450341">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaput</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dawson</surname>
<given-names>K</given-names>
</name>
</person-group>. <article-title>Complexity of type 2 diabetes mellitus data sets emerging from nutrigenomic research: a case for dimensionality reduction?</article-title> <source>Mutat Res</source>. <year>2007</year>;<volume>622</volume>(<issue>1-2</issue>):<fpage>19</fpage>–<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr56-1933719112450341">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakahara</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Carthew</surname>
<given-names>RW</given-names>
</name>
</person-group>. <article-title>Expanding roles for miRNAs and siRNAs in cell regulation</article-title>. <source>Curr Opin Cell Biol</source>. <year>2004</year>;<volume>16</volume>(<issue>2</issue>):<fpage>127</fpage>–<lpage>133</lpage>.</citation>
</ref>
<ref id="bibr57-1933719112450341">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sonkoly</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Stahle</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pivarcsi</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>MicroRNAs: novel regulators in skin inflammation</article-title>. <source>Clin Exp Dermatol</source>. <year>2008</year>;<volume>33</volume>(<issue>3</issue>):<fpage>312</fpage>–<lpage>315</lpage>.</citation>
</ref>
<ref id="bibr58-1933719112450341">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taganov</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Boldin</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Baltimore</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2006</year>;<volume>103</volume>(<issue>33</issue>):<fpage>12481</fpage>–<lpage>12486</lpage>.</citation>
</ref>
<ref id="bibr59-1933719112450341">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bridgham</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>AL</given-names>
</name>
</person-group>. <article-title>Expression and regulation of Fas antigen and tumor necrosis factor receptor type I in hen granulosa cells</article-title>. <source>Biol Reprod</source>. <year>2001</year>;<volume>65</volume>(<issue>3</issue>):<fpage>733</fpage>–<lpage>739</lpage>.</citation>
</ref>
<ref id="bibr60-1933719112450341">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hussein</surname>
<given-names>MR</given-names>
</name>
</person-group>. <article-title>Apoptosis in the ovary: molecular mechanisms</article-title>. <source>Hum Reprod Update</source>. <year>2005</year>;<volume>11</volume>(<issue>2</issue>):<fpage>162</fpage>–<lpage>177</lpage>.</citation>
</ref>
<ref id="bibr61-1933719112450341">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hussein</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Haemel</surname>
<given-names>AK</given-names>
</name>
</person-group>, <article-title>Wood GS. p53-related pathways and the molecular pathogenesis of melanoma</article-title>. <source>Eur J Cancer Prev</source>. <year>2003</year>;<volume>12</volume>(<issue>2</issue>):<fpage>93</fpage>–<lpage>100</lpage>.</citation>
</ref>
<ref id="bibr62-1933719112450341">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzumori</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Matzuk</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Rajkovic</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Nobox is a homeobox-encoding gene preferentially expressed in primordial and growing oocytes</article-title>. <source>Mech Dev</source>. <year>2002</year>;<volume>111</volume>(<issue>1-2</issue>):<fpage>137</fpage>–<lpage>141</lpage>.</citation>
</ref>
<ref id="bibr63-1933719112450341">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajkovic</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pangas</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Ballow</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Suzumori</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Matzuk</surname>
<given-names>MM</given-names>
</name>
</person-group>. <article-title>NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression</article-title>. <source>Science</source>. <year>2004</year>;<volume>305</volume>(<issue>5687</issue>):<fpage>1157</fpage>–<lpage>1159</lpage>.</citation>
</ref>
<ref id="bibr64-1933719112450341">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sluijter</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>van Mil</surname>
<given-names>A</given-names>
</name>
<name>
<surname>van Vliet</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group> <article-title>MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. <year>2010</year>;<volume>30</volume>(<issue>4</issue>):<fpage>859</fpage>–<lpage>868</lpage>.</citation>
</ref>
<ref id="bibr65-1933719112450341">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murakami</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ishida</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Thurlow</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Revest</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Dickson</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>SOX6 binds CtBP2 to repress transcription from the Fgf-3 promoter</article-title>. <source>Nucleic Acids Res</source>. <year>2001</year>;<volume>29</volume>(<issue>16</issue>):<fpage>3347</fpage>–<lpage>3355</lpage>.</citation>
</ref>
<ref id="bibr66-1933719112450341">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jakobovits</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shackleford</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Varmus</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>GR</given-names>
</name>
</person-group>. <article-title>Two proto-oncogenes implicated in mammary carcinogenesis, int-1 and int-2, are independently regulated during mouse development</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1986</year>;<volume>83</volume>(<issue>20</issue>):<fpage>7806</fpage>–<lpage>7810</lpage>.</citation>
</ref>
<ref id="bibr67-1933719112450341">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srivatsan</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Misra</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Venugopalan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wilczynski</surname>
<given-names>SP</given-names>
</name>
</person-group>. <article-title>Loss of heterozygosity for alleles on chromosome II in cervical carcinoma</article-title>. <source>Am J Hum Genet</source>. <year>1991</year>;<volume>49</volume>(<issue>4</issue>):<fpage>868</fpage>–<lpage>877</lpage>.</citation>
</ref>
<ref id="bibr68-1933719112450341">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naidu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wahab</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Yadav</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kutty</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Nair</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Detection of amplified int-2/FGF-3 gene in primary breast carcinomas using differential polymerase chain reaction</article-title>. <source>Int J Mol Med</source>. <year>2001</year>;<volume>8</volume>(<issue>2</issue>):<fpage>193</fpage>–<lpage>198</lpage>.</citation>
</ref>
<ref id="bibr69-1933719112450341">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shalgi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lieber</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Oren</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pilpel</surname>
<given-names>Y</given-names>
</name>
</person-group>. <article-title>Global and local architecture of the mammalian microRNA-transcription factor regulatory network</article-title>. <source>PLoS Comput Biol</source>. <year>2007</year>;<volume>3</volume>(<issue>7</issue>):<fpage>e131</fpage>.</citation>
</ref>
<ref id="bibr70-1933719112450341">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sober</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Laan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Annilo</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>MicroRNAs miR-124 and miR-135a are potential regulators of the mineralocorticoid receptor gene (NR3C2) expression</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2010</year>;<volume>391</volume>(<issue>1</issue>):<fpage>727</fpage>–<lpage>732</lpage>.</citation>
</ref>
<ref id="bibr71-1933719112450341">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>QK</given-names>
</name>
<etal/>
</person-group> <article-title>A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma</article-title>. <source>Carcinogenesis</source>. <year>2008</year>;<volume>29</volume>(<issue>11</issue>):<fpage>2126</fpage>–<lpage>2131</lpage>.</citation>
</ref>
<ref id="bibr72-1933719112450341">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jazdzewski</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Franssila</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Jarzab</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Schoenberg</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>de la Chapelle</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2008</year>;<volume>105</volume>(<issue>20</issue>):<fpage>7269</fpage>–<lpage>7274</lpage>.</citation>
</ref>
<ref id="bibr73-1933719112450341">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vitiello</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kodaman</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
</person-group>. <article-title>HOX genes in implantation</article-title>. <source>Semin Reprod Med</source>. <year>2007</year>;<volume>25</volume>(<issue>6</issue>):<fpage>431</fpage>–<lpage>436</lpage>.</citation>
</ref>
<ref id="bibr74-1933719112450341">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schimanski</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Frerichs</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group> <article-title>High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells</article-title>. <source>World J Gastroenterol</source>. <year>2009</year>;<volume>15</volume>(<issue>17</issue>):<fpage>2089</fpage>–<lpage>2096</lpage>.</citation>
</ref>
<ref id="bibr75-1933719112450341">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Makker</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Goel</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Anjoo</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: an update</article-title>. <source>Gynecol Endocrinol</source>. <year>2012</year>;<volume>28</volume>(<issue>3</issue>):<fpage>175</fpage>–<lpage>181</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>